Here are recent financial transactions for science- and engineering-based companies reported by Xconomy.
Biomedical/Life Sciences
AcelRx Pharmaceuticals in Redwood City, California. Pain medications. $40 million IPO: 8 million shares @ $5.00.
Optimer Pharmaceuticals in San Diego, California. Antibiotics. $67.5 million stock offering: 6 million shares @ $11.25.
Fluidigm in South San Francisco, California. $75.6 million IPO: 5.6 million shares @ $13.50.
Arsanis in Lebanon, New Hampshire. Biotechnology. $9.6 million, equity.
Marina Biotech in Bothell, Washington. Cancer drugs. $5.1 million, equity.
Dendreon in Seattle, Washington. Cancer drugs. $80 million, debt.
Oncothyreon in Seattle, Washington. Cancer drugs. $12.5 million, debt.
Seattle Genetics in Bothell, Washington. Cancer drugs. $23.25 million stock offering: 1.5 million shares @ $15.50.
Ecochlor in Acton, Massachusetts. Industrial anti-pathogen systems. $1.7 million, equity.
Physical Sciences
Shocking Technologies in San Jose, California, Polymer dielectric materials. $5.2 million, equity.
Engineering and Electronics
Tela Innovations in Los Gatos, California. Semiconductor fabrication. $4.75 million, equity.
Read more: Finance Friday: 28 January 2011
* * *
You must be logged in to post a comment.